Freedom of Information Act request reveals communications between FBI & Pfizer about Project Veritas

Freedom of Information/Privacy Acts (FOIPA) response letters from the Department of Justice have revealed that there has been some level of communication between the bureau and pharmaceutical company Pfizer regarding Project Veritas.

The response letters, originally obtained by Judicial Watch and revealed to Project Veritas, came from requests made by the legal watchdog group requesting any communications the federal department and company had, citing separate requests in each instance, according to Project Veritas.

The second letter reportedly cited "an unwarranted invasion of personal privacy" regarding the request.

The first letter states that the requested files are located in an "investigative file," which makes the documents "exempt from disclosure."

"The FBI has completed its search for records responsive to your request. The material you requested is located in an investigative file which is exempt from disclosure pursuant to 5 U.S.C. § 552(b)(7)(A). 552(b)(7)(A) exempts from disclosure: Records or information compiled for law enforcement purposes, but only to the extent that the production of such law enforcement records or information ... could reasonably be expected to interfere with enforcement proceedings…" the letter states.

"It's unclear why Pfizer, one of the world's largest pharmaceutical companies would be communicating with the Federal Bureau of Investigation about journalists or journalism done on Pfizer," said Project Veritas founder James O’Keefe.

O’Keefe noted a statement given by Pfizer CEO Albert Bourla on November 9, 2021, stating that he is in contact with the FBI and CIA regarding "misinformation."

There was — particularly with us we were targeted by a lot of — it's a dark organizations that you don't really know the ownership, we suspect that there are some countries behind, we we’re getting a lot of briefings from CIA, from FBI about the attacks that may happen to us, cyber attacks, I mean, but also about the spread of misinformation," said Bourla.

Bourla’s statement came around month after a couple of investigative reports from Project Veritas. In one instance, an undercover reporter captured a Pfizer scientist stating on camera that an unvaccinated person that gets the virus most likely has better antibodies than someone who got vaccinated.

Another report came when a whistleblower revealed emails from a senior director at Pfizer named Vanessa Gelman, in which Gelman stated that she does not want information regarding fetal cells in the development of vaccines out in the public.

"So the question is, why would Pfizer, a pharmaceutical company, be talking to the FBI about Project Veritas right after those pieces of reporting I just showed you? Why is a pharmaceutical company and the Federal Bureau of Investigation having conversations about journalists in the United States of America?" O’Keefe questioned.

"Is this another example of the Department of Justice being weaponized by corporate and political interests? Is this another attack on the First Amendment and an attack on journalists?" he continued.

In response to the release of the FOIPA response letters, Project Veritas released the following statement:

"It is troubling, not just that Pfizer apparently believes it can rely on the FBI to squash truthful reporting via investigations into law-abiding journalists, but also that they appear to be right in thinking the FBI will willingly target dissenting press with unconstitutional raids.  There should be no place for such retaliatory attacks on journalism in America."